Sonnet BioTherapeutics Holdings, Inc. (SONN) After-Market Surge Spurs Investor Interest
Sonnet BioTherapeutics Holdings, Inc. (SONN) experienced a notable surge in after-market trading on Thursday, with the stock price reaching $1.05, representing a change percentage of 13.02%. The surge, although unattributed to any specific reason, has captured the attention of investors, prompting them to evaluate the investment potential of SONN stock. Financial Results and Cash Position […]
